Saturday, December 15, 2007

mylan

Updated Date: Dec 12, 27 EST.
Mylan Inc. (NYSE: MYL) today announced
that it and its subsidiary Mylan Pharmaceuticals Inc. have entered
into a patent license and settlement agreement with GlaxoSmithKline
(GSK) relating to Paroxetine Hydrochloride (HCl) ...
Mylan Inc. (NYSE:
MYL) today announced the appointment of Steven G. Zylstra as Vice
President, Global Corporate Communication and Public Relations. Mr.
Read More at Press Trust of India…
Mylan Inc. (NYSE: MYL) today
announced the appointment of Steven G. Zylstra as Vice President,
Global Corporate Communication and Public Relations. Mr. Read More at
Press Trust of India…
MYLAN INC. Files SEC form 8-K, Current report
filing.
Mylan Inc announced that it and its subsidiary, Mylan
Pharmaceuticals, have in place an agreement with GlaxoSmithKline Plc's
(NYSE:GSK) to settle all litigation and also have in place a patent
license agreement. ...
BOSTON (Thomson Financial) - Critical
Therapeutics Inc. said Monday it received a $5 million milestone
payment from Dey LP, a subsidiary of Mylan Inc., related to a
co-promotion agreement between the companies for Zyflo CR
...
Exogenous testosterone or testosterone with generic propecia 5mg
mylan increases bone mineral tightness in older men with low serum
testosterone. The course snowfall of fixed charge in testosterone
backup man therapy reminds us of the ...
Pharmaceutical company Mylan
on Tuesday announced that it has received tentative FDA approval for
its generic version of Gilead Sciences' antiretroviral drug Viread for
use in the President's Emergency Plan for AIDS Relief, the AP/Yahoo
...
Cecil-based Mylan ready to 'hunker down' after buying Merck's
worldwide generic drug operations.
Mylan Inc announced that it and its
subsidiary, Mylan Pharmaceuticals, have in place an agreement with
GlaxoSmithKline Plc's (NYSE:GSK) to settle all litigation and also
have in place a patent license agreement. ...
Pharmaceutical company
Mylan on Tuesday announced that it has received tentative FDA approval
for its generic version of Gilead Sciences' antiretroviral drug Viread
for use in the President's Emergency Plan for AIDS Relief, the
AP/Yahoo ...
Datamonitor's Mylan Laboratories Inc SWOT company profile
is the essential source for top-level company data and information.
The report examines the company's key business structure and
operations, history and products, and provides ...
Updated Date: Dec
12, 27 EST.
MYLAN INC. Files SEC form 8-K, Current report
filing.
Mylan Inc., the Pittsburgh drugmaker, said its 71.5
percent-owned Indian subsidiary, Matrix Laboratories, received
tentative clearance from the US Food and Drug Administration to market
tenofovir disoproxil fumarate tablets in a ...
Forest licenses blood
pressure drug from Mylan. Mylan completes acquisition of Merck
KGaA’s generics unit. Licensing deal with Microbia reduces Forest
Labs' financials. Licensing deal with Microbia reduces Forest Labs'
financials ...

0 comments: